Lipid-modifying activity of curcuminoids: A systematic review and meta-analysis of randomized controlled trials.

about

Lipid-modifying activity of curcuminoids: A systematic review and meta-analysis of randomized controlled trials.

Item

http://www.wikidata.org/entity/Q47398352

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Lipid-modifying activity of cu ...... randomized controlled trials.

@en

Lipid-modifying activity of cu ...... randomized controlled trials.

@nl

type

Item

label

Lipid-modifying activity of cu ...... randomized controlled trials.

@en

Lipid-modifying activity of cu ...... randomized controlled trials.

@nl

prefLabel

Lipid-modifying activity of cu ...... randomized controlled trials.

@en

Lipid-modifying activity of cu ...... randomized controlled trials.

@nl

P1476

Lipid-modifying activity of cu ...... randomized controlled trials.

@en

P2093

Antonio M Gotto

http://www.w3.org/2001/XMLSchema#string

Luis E Simental-Mendía

http://www.w3.org/2001/XMLSchema#string

Muhammed Majeed

http://www.w3.org/2001/XMLSchema#string

Stephen L Atkin

http://www.w3.org/2001/XMLSchema#string

P2860

Estimating the mean and variance from the median, range, and the size of a sample

Triglycerides and Triglyceride-Rich Lipoproteins in the Causal Pathway of Cardiovascular Disease

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Bioavailability of curcumin: problems and promises

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk.

Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification (REVEAL)-A large-scale, randomized, placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease: Trial design, recruitm

HDL metabolism in hypertriglyceridemic states: an overview.

Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis.

P304

1-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1080/10408398.2017.1396201

http://www.w3.org/2001/XMLSchema#string

P50

Maciej Banach

Matteo Pirro

Amirhossein Sahebkar

P577

2017-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29185808

http://www.w3.org/2001/XMLSchema#string